| Product Description |
Code Info |
Classification |
Reason for Recall |
Product Quantity |
Recall Number |
| Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #HB01212 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
1,923,887 tablets |
D-074-2013 |
| Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #1097830 exp. 1/31/2013 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
13,692/100-tablet bottles |
D-075-2013 |
| Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #HA31411 and #HE17811 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
3,826,269 tablets |
D-076-2013 |
| Levothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, Rx only, NDC 0456-1329-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #1096369, exp. 11/30/2012; and #1092046, exp. 7/31/2012 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
31,252/100-tablet bottles |
D-077-2013 |
| Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #HC31411 and #HE18711 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
3,813,645 tablets |
D-078-2013 |
| Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, Rx only, NDC 0456-1330-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #1096371, exp. 5/312013; and #1092299, exp. 1/31/2013 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
37,827/100-tablet bottles |
D-079-2013 |
| Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #HB27811 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
1,924,174 tablets |
D-080-2013 |
| Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #1095210, exp. 4/30/2013 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
19,162/100-tablet bottles |
D-081-2013 |
| Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #HA27911 and #HA12511 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
3,774,541 tablets |
D-082-2013 |
| Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #1095212 exp. 4/30/2013; and #1088877, exp. 11/30/2012 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
36,978/100-tablet bottles |
D-083-2013 |
| Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #HE35311 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
1,902,957 tablets |
D-084-2013 |
| Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, Rx only, NDC 0456-1328-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. |
Lot #1097178 exp. 7/31/2013 |
Class II |
cGMP Deviations; does not meet in process specification requirements |
1,443/100-tablet bottles |
D-085-2013 |